Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium ulcerans | polyketide synthase Pks13 | 0.0098 | 0.0938 | 0.0938 |
Mycobacterium ulcerans | Type I modular polyketide synthase | 0.0073 | 0.0565 | 0.0565 |
Mycobacterium tuberculosis | 3-oxoacyl-[acyl-carrier protein] synthase 2 KasB (beta-ketoacyl-ACP synthase) (KAS I) | 0.0046 | 0.0142 | 0.0095 |
Wolbachia endosymbiont of Brugia malayi | 3-oxoacyl-ACP synthase | 0.0683 | 1 | 1 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks9 | 0.0052 | 0.0239 | 0.0193 |
Brugia malayi | oxidoreductase, zinc-binding dehydrogenase family protein | 0.0117 | 0.124 | 1 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSA | 0.0073 | 0.0565 | 0.581 |
Echinococcus granulosus | 3 oxoacyl acyl carrier protein synthase | 0.0083 | 0.0713 | 0.5 |
Mycobacterium ulcerans | 3-oxoacyl-ACP synthase | 0.0683 | 1 | 1 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSB | 0.0064 | 0.0418 | 0.4155 |
Mycobacterium tuberculosis | Phenyloxazoline synthase MbtB (phenyloxazoline synthetase) | 0.0046 | 0.0134 | 0.0086 |
Loa Loa (eye worm) | fatty acid synthase | 0.0048 | 0.0173 | 0.0418 |
Mycobacterium ulcerans | beta-ketoacyl synthase-like protein | 0.0683 | 1 | 1 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsD | 0.0073 | 0.0565 | 0.0565 |
Mycobacterium ulcerans | multifunctional mycocerosic acid synthase membrane-associated Mas | 0.0076 | 0.0612 | 0.0612 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSE | 0.0057 | 0.0309 | 0.2941 |
Mycobacterium tuberculosis | Probable thioesterase TesA | 0.0041 | 0.0057 | 0.001 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks15 | 0.0044 | 0.0116 | 0.0068 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsA | 0.0064 | 0.0418 | 0.0418 |
Loa Loa (eye worm) | beta-ketoacyl synthase domain-containing protein | 0.0083 | 0.0713 | 0.6138 |
Toxoplasma gondii | beta-ketoacyl synthase, N-terminal domain-containing protein | 0.0056 | 0.03 | 0.2074 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0089 | 0.0802 | 0.5 |
Mycobacterium leprae | Probable polyketide synthase Pks1 | 0.0076 | 0.0612 | 0.6337 |
Plasmodium vivax | beta-ketoacyl-acyl carrier protein synthase III precursor, putative | 0.0683 | 1 | 1 |
Leishmania major | beta-ketoacyl synthase family protein, putative,3-oxoacyl-acyl carrier protein synthase ii, putative | 0.0083 | 0.0713 | 0.5 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks5 | 0.0072 | 0.0542 | 0.0497 |
Mycobacterium ulcerans | 3-oxoacyl-ACP synthase | 0.0683 | 1 | 1 |
Mycobacterium tuberculosis | Probable membrane bound polyketide synthase Pks6 | 0.0098 | 0.0938 | 0.0895 |
Mycobacterium leprae | PROBABLE THIOESTERASE TESA | 0.0041 | 0.0057 | 0.0111 |
Onchocerca volvulus | 0.0109 | 0.1123 | 0.9548 | |
Mycobacterium ulcerans | 3-oxoacyl-(acyl carrier protein) synthase II | 0.0083 | 0.0713 | 0.0713 |
Mycobacterium tuberculosis | Polyketide synthase Pks13 | 0.0098 | 0.0938 | 0.0895 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks8 | 0.0065 | 0.0427 | 0.0382 |
Mycobacterium ulcerans | thioesterase | 0.0041 | 0.0057 | 0.0057 |
Brugia malayi | Beta-ketoacyl synthase, N-terminal domain containing protein | 0.0083 | 0.0713 | 0.5236 |
Echinococcus multilocularis | 3 oxoacyl (acyl carrier protein) synthase | 0.0083 | 0.0713 | 0.5 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks7 | 0.0076 | 0.0612 | 0.0567 |
Mycobacterium tuberculosis | Polyketide synthetase MbtC (polyketide synthase) | 0.0041 | 0.007 | 0.0022 |
Loa Loa (eye worm) | hypothetical protein | 0.0052 | 0.0233 | 0.1055 |
Mycobacterium leprae | Probable multifunctional mycocerosic acid synthase membrane associated enzyme Mas | 0.0076 | 0.0612 | 0.6337 |
Mycobacterium ulcerans | Type I modular polyketide synthase | 0.0073 | 0.0565 | 0.0565 |
Mycobacterium ulcerans | polyketide synthase | 0.0076 | 0.0612 | 0.0612 |
Toxoplasma gondii | type I fatty acid synthase, putative | 0.0076 | 0.0612 | 0.8056 |
Brugia malayi | Beta-ketoacyl synthase, N-terminal domain containing protein | 0.0073 | 0.0565 | 0.3897 |
Trypanosoma cruzi | beta-ketoacyl synthase family protein, putative | 0.0083 | 0.0713 | 0.5 |
Onchocerca volvulus | Fatty acid synthase homolog | 0.0113 | 0.117 | 1 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSC | 0.0076 | 0.0612 | 0.6337 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0089 | 0.0802 | 0.5 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsB | 0.0064 | 0.0418 | 0.0418 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSD | 0.0073 | 0.0565 | 0.581 |
Mycobacterium leprae | Polyketide synthase Pks13 | 0.0098 | 0.0938 | 1 |
Toxoplasma gondii | type I fatty acid synthase, putative | 0.0059 | 0.0348 | 0.2987 |
Loa Loa (eye worm) | hypothetical protein | 0.0107 | 0.1078 | 1 |
Toxoplasma gondii | 3-oxoacyl-acyl-carrier protein synthase I/II, putative | 0.0083 | 0.0713 | 1 |
Mycobacterium ulcerans | fatty acid synthase Fas | 0.004 | 0.0048 | 0.0048 |
Trypanosoma brucei | beta-ketoacyl-ACP synthase | 0.0083 | 0.0713 | 0.5 |
Mycobacterium tuberculosis | Phenolpthiocerol synthesis type-I polyketide synthase PpsC | 0.0073 | 0.0565 | 0.052 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0089 | 0.0802 | 0.5 |
Mycobacterium ulcerans | 3-oxoacyl-(acyl carrier protein) synthase II | 0.0083 | 0.0713 | 0.0713 |
Trypanosoma cruzi | beta-ketoacyl synthase family protein, putative | 0.0083 | 0.0713 | 0.5 |
Mycobacterium tuberculosis | 3-oxoacyl-[acyl-carrier protein] synthase 1 KasA (beta-ketoacyl-ACP synthase) (KAS I) | 0.0046 | 0.0142 | 0.0095 |
Schistosoma mansoni | 3-oxoacyl-[ACP] synthase | 0.0083 | 0.0713 | 0.5 |
Mycobacterium leprae | 3-oxoacyl-[acyl-carrier-protein] synthase 1 KasA (BETA-KETOACYL-ACP SYNTHASE) (KAS I) | 0.0046 | 0.0142 | 0.1061 |
Mycobacterium leprae | 3-oxoacyl-[acyl-carrier-protein] synthase 2 KasB (BETA-KETOACYL-ACP SYNTHASE) (KAS I) | 0.0046 | 0.0142 | 0.1061 |
Plasmodium falciparum | beta-ketoacyl-ACP synthase III | 0.0683 | 1 | 1 |
Mycobacterium tuberculosis | Phenolpthiocerol synthesis type-I polyketide synthase PpsA | 0.0073 | 0.0565 | 0.052 |
Mycobacterium ulcerans | polyketide synthase | 0.0073 | 0.0565 | 0.0565 |
Mycobacterium ulcerans | Type I modular polyketide synthase | 0.0073 | 0.0565 | 0.0565 |
Mycobacterium tuberculosis | Polyketide synthase Pks2 | 0.0072 | 0.0542 | 0.0497 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsE | 0.0057 | 0.0309 | 0.0309 |
Mycobacterium tuberculosis | Polyketide synthase Pks12 | 0.0076 | 0.0612 | 0.0567 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0089 | 0.0802 | 0.5 |
Mycobacterium ulcerans | thioesterase TesA | 0.0041 | 0.0057 | 0.0057 |
Mycobacterium tuberculosis | Probable multifunctional mycocerosic acid synthase membrane-associated Mas | 0.0076 | 0.0612 | 0.0567 |
Mycobacterium tuberculosis | Phenolpthiocerol synthesis type-I polyketide synthase PpsD | 0.0073 | 0.0565 | 0.052 |
Mycobacterium tuberculosis | 3-oxoacyl-[acyl-carrier-protein] synthase III FabH (beta-ketoacyl-ACP synthase III) (KAS III) | 0.0683 | 1 | 1 |
Mycobacterium ulcerans | polyketide synthase Pks9 | 0.0057 | 0.0309 | 0.0309 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsC | 0.0076 | 0.0612 | 0.0612 |
Entamoeba histolytica | fatty acid elongase, putative | 0.0089 | 0.0802 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Inhibition (functional) | = 38 % | Antagonist activity at P2Y12 receptor (unknown origin) assessed as platelet aggregation at 30 uM by washed platelet assay | ChEMBL. | 18276138 |
Inhibition (functional) | = 38 % | Antagonist activity at P2Y12 receptor (unknown origin) assessed as platelet aggregation at 30 uM by washed platelet assay | ChEMBL. | 18276138 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.